申请人:Bayer Aktiengesellschaft
公开号:US05137901A1
公开(公告)日:1992-08-11
For binding 5-HT.sub.1 receptors and thereby treating central nervous system disorders, novel substituted aminomethyltetralins and their heterocyclic analogues of the formula ##STR1## in which Z--denotes a group of the formula ##STR2## R.sup.1, E and F can be hydrogen or other radicals, or salts thereof.
用于结合5-HT.sub.1受体从而治疗中枢神经系统疾病的新型取代氨甲基四环素和其杂环类似物的公式为##STR1##其中Z-表示公式##STR2##的基团,R.sup.1,E和F可以是氢或其他基团,或其盐。